Published in Am J Physiol on October 01, 1990
Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluation. AAPS PharmSciTech (2013) 0.78
Modified methods for the determination of carbamyl aspartate. Anal Biochem (1969) 3.52
Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis. Annu Rev Biochem (1980) 3.31
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother (1998) 3.21
Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol (2000) 3.13
Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis (2000) 2.87
Occult rickets and osteomalacia amongst the Asian immigrant population. Q J Med (1973) 2.58
Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother (2001) 2.39
Typing of methicillin-resistant Staphylococcus aureus isolates from Düsseldorf by six genotypic methods. J Med Microbiol (1998) 2.39
Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci U S A (1993) 2.35
Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J Clin Microbiol (1999) 2.12
Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria. Lancet (1997) 1.96
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J Antimicrob Chemother (2000) 1.93
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob Agents Chemother (1998) 1.91
Toxin involvement in staphylococcal scalded skin syndrome. Clin Infect Dis (1997) 1.88
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe. Antimicrob Agents Chemother (1999) 1.75
Estrogen and spermatogenesis. Endocr Rev (2001) 1.73
The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother (1998) 1.71
Thermal environment and sudden infant death syndrome: case-control study. BMJ (1992) 1.70
The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J Antimicrob Chemother (1999) 1.68
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. J Antimicrob Chemother (1999) 1.65
Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene. Proc Natl Acad Sci U S A (1999) 1.64
Isometric lifting strength as a predictor of industrial back pain reports. Spine (Phila Pa 1976) (1989) 1.63
Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1998) 1.61
Mortality during 25 years of follow-up of a cohort with diabetes. Int J Epidemiol (1996) 1.58
Estrogen--the good, the bad, and the unexpected. Endocr Rev (2005) 1.57
Carbamyl phosphate: an allosteric substrate for aspartate transcarbamylase of Escherichia coli. Proc Natl Acad Sci U S A (1968) 1.51
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1998) 1.48
A modified Luria-Delbrück fluctuation assay for estimating and comparing mutation rates. Mutat Res (1996) 1.47
Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. Radiology (1997) 1.46
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. Antimicrob Agents Chemother (2001) 1.45
Noradrenaline and motor transmission in the vas deferens of the mouse. Br J Pharmacol (1975) 1.44
Uridylic acid synthesis in Ehrlich ascites carcinoma. Properties, subcellular distribution, and nature of enzyme complexes of the six biosynthetic enzymes. Biochemistry (1973) 1.43
Uridine-responsive hypogammaglobulinemia and congenital heart disease in a patient with hereditary orotic aciduria. J Pediatr (1988) 1.42
Iron uptake by human reticulocytes at physiologic and sub-physiologic concentrations of iron transferrin: the effect of interaction with aluminum transferrin. Blood (1991) 1.40
An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology (2000) 1.31
Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents (2001) 1.30
Molecular size and feedback-regulation characteristics of bacterial asartate transcarbamulases. Arch Biochem Biophys (1969) 1.29
Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology (2001) 1.25
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study. Int J Obes (Lond) (2010) 1.23
Drugs and human memory: effects of low doses of nitrazepam and hyoscine on retention. Br J Clin Pharmacol (1979) 1.22
Age-related changes in pharyngeal and supraglottic sensation. Ann Otol Rhinol Laryngol (1994) 1.21
Kinetic studies of the transfer of esterified cholesterol between human plasma low and high density lipoproteins. J Lipid Res (1980) 1.20
Multiple-system atrophy: a new alpha-synuclein disease? Lancet (1998) 1.18
Standardized percentile curves of body mass index of Iranian children compared to the US population reference. Int J Obes Relat Metab Disord (1999) 1.12
A unique catalytic and inhibitor-binding role for Lys93 of yeast orotidylate decarboxylase. Biochemistry (1992) 1.12
Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J Neurochem (1999) 1.12
Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci. J Antimicrob Chemother (1996) 1.10
Investigation of the enzymatic mechanism of yeast orotidine-5'-monophosphate decarboxylase using 13C kinetic isotope effects. Biochemistry (1991) 1.09
The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology. Br J Cancer (2011) 1.09
Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997. Antonie Van Leeuwenhoek (2000) 1.09
The pulmonary consequences of a deep breath. Respir Physiol (1982) 1.08
Inorganic phosphate determination in the presence of a labile organic phosphate: assay for carbamyl phosphate phosphatase activity. Anal Biochem (1983) 1.08
In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe. Clin Microbiol Infect (2002) 1.06
A simple centrifuge column for desalting protein solutions. Anal Biochem (1979) 1.06
Pyrimethamine/sulfadoxine resistant falciparum malaria in East Africa. Lancet (1982) 1.06
Cutaneous overexpression of NT-3 increases sensory and sympathetic neuron number and enhances touch dome and hair follicle innervation. J Cell Biol (1996) 1.05
The cellular location of dihydroorotate dehydrogenase: relation to de novo biosynthesis of pyrimidines. Arch Biochem Biophys (1976) 1.05
Intrinsic activity and stability of bifunctional human UMP synthase and its two separate catalytic domains, orotate phosphoribosyltransferase and orotidine-5'-phosphate decarboxylase. J Biol Chem (1996) 1.05
Regulation of pyrimidine and arginine biosynthesis in mammals. Adv Enzyme Regul (1970) 1.05
Mental health consultation improves care of the aged in community facilities. Hosp Community Psychiatry (1974) 1.04
The overall synthesis of L-5,6-dihydroorotate by multienzymatic protein pyr1-3 from hamster cells. Kinetic studies, substrate channeling, and the effects of inhibitors. J Biol Chem (1980) 1.04
Orotidylate decarboxylase: insights into the catalytic mechanism from substrate specificity studies. Biochemistry (1992) 1.04
Uracil metabolism--UMP synthesis from orotic acid or uridine and conversion of uracil to beta-alanine: enzymes and cDNAs. Prog Nucleic Acid Res Mol Biol (1996) 1.04
Evidence that disease-induced population decline changes genetic structure and alters dispersal patterns in the Tasmanian devil. Heredity (Edinb) (2010) 1.04
Purification and characterization of yeast orotidine 5'-monophosphate decarboxylase overexpressed from plasmid PGU2. J Biol Chem (1991) 1.01
Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance network. J Antimicrob Chemother (1999) 1.01
Expression and sequence analysis of a cDNA encoding the orotidine-5'-monophosphate decarboxylase domain from Ehrlich ascites uridylate synthase. J Biol Chem (1986) 1.01
Phospholipid lateral organization in synthetic membranes as monitored by pyrene-labeled phospholipids: effects of temperature and prothrombin fragment 1 binding. Biochemistry (1986) 0.99
The ovarian phenotype of the aromatase knockout (ArKO) mouse. J Steroid Biochem Mol Biol (2001) 0.99
Initial steps in pyrimidine synthesis in Ehrlich ascites carcinoma in vitro. II. The synthesis of carbamyl phosphate by a soluble, glutamine-dependent carbamyl phosphate synthetase. J Biol Chem (1967) 0.99
The road to ovulation: the role of oestrogens. Reprod Fertil Dev (2001) 0.98
Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study. Br J Cancer (2010) 0.98
The Structure of Stable Pentaborane. Proc Natl Acad Sci U S A (1952) 0.98
Purification, composition, and some properties of rat liver carbamyl phosphate synthetase (ammonia). Arch Biochem Biophys (1976) 0.98
Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology (2003) 0.97
Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004). Int J Antimicrob Agents (2006) 0.97
Composition of human pulmonary surfactant varies with exercise and level of fitness. Am J Respir Crit Care Med (1994) 0.96
Evaluation of family physician prescribing: influence of the clinical pharmacist. Drug Intell Clin Pharm (1984) 0.95
Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group. Int J Infect Dis (1999) 0.95
Inhibitors of orotate phosphoribosyl-transferase and orotidine-5'-phosphate decarboxylase from mouse Ehrlich ascites cells: a procedure for analyzing the inhibition of a multi-enzyme complex. Biochem Pharmacol (1977) 0.94
Orotidine-5'-monophosphate decarboxylase catalysis: kinetic isotope effects and the state of hybridization of a bound transition-state analogue. Biochemistry (1990) 0.94
Ornithine synthesis from glutamate in rat intestinal mucosa homogenates: evidence for the reduction of glutamate to gamma-glutamyl semialdehyde. Biochem Biophys Res Commun (1978) 0.94
Lung function, permeability, and surfactant composition in oleic acid-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol (2000) 0.94
Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? Int J Antimicrob Agents (1997) 0.94
Purification and characteristics of aspartate transcarbamylase from Pseudomonas fluorescens. J Biol Chem (1972) 0.93
Prevalence of molecular types and mecA gene carriage of coagulase-negative Staphylococci in a neonatal intensive care unit: relation to nosocomial septicemia. J Clin Microbiol (2001) 0.93
Kinetic and conformational studies of the orotate phosphoribosyltransferase:orotidine-5'-phosphate decarboxylase enzyme complex from mouse Ehrlich ascites cells. J Biol Chem (1977) 0.92
Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am J Respir Crit Care Med (1998) 0.92
Initial steps in pyrimidine synthesis in Ehrlich ascites carcinoma. Biochem Biophys Res Commun (1971) 0.92
Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes. Biochem Pharmacol (1988) 0.92
Conversion of glutamate to ornithine and proline: pyrroline-5-carboxylate, a possible modulator of arginine requirements. J Nutr (1985) 0.92
Cyclic stretch induces both apoptosis and secretion in rat alveolar type II cells. FEBS Lett (1999) 0.91
Osmotic stress induces both secretion and apoptosis in rat alveolar type II cells. Am J Physiol (1998) 0.91
Effects of capitation payment for pharmacy services on pharmacist-dispensing and physician-prescribing behavior: II. Therapeutic category analysis, over-the-counter drug usage, and drug interactions. Drug Intell Clin Pharm (1981) 0.91
Delta 1-pyrroline-5-carboxylate synthase from rat intestinal mucosa. Methods Enzymol (1985) 0.91
Comparison of the abilities of synthetic and platelet-derived membranes to enhance thrombin formation. Thromb Res (1985) 0.91